<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Among patients with non-ST-segment elevation <z:hpo ids='HP_0011009'>acute</z:hpo> coronary syndromes, recurrent <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> and <z:hpo ids='HP_0004308'>ventricular arrhythmias</z:hpo> detected on continuous electrocardiographic monitoring remain common events that are associated with worse outcomes </plain></SENT>
<SENT sid="1" pm="."><plain>The relative clinical significance of both events together is not well described </plain></SENT>
<SENT sid="2" pm="."><plain>We determined the risk associated with <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> (≥1 mm ST <z:hpo ids='HP_0000716'>depression</z:hpo> lasting ≥1 minutes) and <z:hpo ids='HP_0004756'>ventricular tachycardia</z:hpo> (VT) (≥4 beats) detected on 7-day continuous electrocardiographic monitoring in 6,355 patients with non-ST-segment elevation <z:hpo ids='HP_0011009'>acute</z:hpo> coronary syndromes from the Metabolic Efficiency with Ranolazine for Less <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">Ischemia</z:e> in Non-ST-elevation <z:hpo ids='HP_0011009'>Acute</z:hpo> Coronary Syndrome-Thrombolysis In <z:hpo ids='HP_0001658'>Myocardial Infarction</z:hpo> (MERLIN-TIMI) 36 trial </plain></SENT>
<SENT sid="3" pm="."><plain>The patients were categorized into 4 groups according to the presence or absence of VT and <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>Cardiovascular <z:hpo ids='HP_0011420'>death</z:hpo>, <z:hpo ids='HP_0001645'>sudden cardiac death</z:hpo> (SCD), <z:hpo ids='HP_0001658'>myocardial infarction</z:hpo>, and recurrent <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> were assessed during a median follow-up of 348 days </plain></SENT>
<SENT sid="5" pm="."><plain>A total of 60.0% patients had no VT or <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>, 20.0% had VT alone, 14.7% had <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> alone, and 5.3% had both </plain></SENT>
<SENT sid="6" pm="."><plain>The patients with either VT or <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> were at increased risk of cardiovascular outcomes </plain></SENT>
<SENT sid="7" pm="."><plain>The combination of <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> and VT identified a particularly high-risk population for cardiovascular <z:hpo ids='HP_0011420'>death</z:hpo> (10.1% vs 3.0%, p &lt;0.001), SCD (7.8% vs 0.9%, p &lt;0.001), and <z:hpo ids='HP_0001658'>myocardial infarction</z:hpo> (15.4% vs 6.2%, p &lt;0.001) compared to patients with neither </plain></SENT>
<SENT sid="8" pm="."><plain>The addition of <z:hpo ids='HP_0011675'>arrhythmia</z:hpo> and <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> significantly improved the clinical model for predicting cardiovascular <z:hpo ids='HP_0011420'>death</z:hpo> or SCD (p &lt;0.001) </plain></SENT>
<SENT sid="9" pm="."><plain>In patients with both <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> and VT, 66.6% of SCD occurred within 90 days of the non-ST-segment elevation <z:hpo ids='HP_0011009'>acute</z:hpo> coronary syndromes </plain></SENT>
<SENT sid="10" pm="."><plain>In conclusion, in &gt;6,300 patients with non-ST-segment elevation <z:hpo ids='HP_0011009'>acute</z:hpo> coronary syndromes, the presence of <z:e sem="disease" ids="C0151744" disease_type="Disease or Syndrome" abbrv="IHD">myocardial ischemia</z:e> or VT alone, and particularly in combination, was independently associated with poor cardiovascular outcomes and thus provides incremental improvement in early risk stratification </plain></SENT>
</text></document>